Cholecystitis; Gangrenous Clinical Trial
Official title:
European Society for Trauma and Emergency Surgery (ESTES) Cohort Study Snapshot Audit 2018 - Acute Complicated Biliary Disease
Verified date | July 2019 |
Source | European Socierty for Trauma and Emergency Surgery |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
To explore differences in patients, techniques and outcomes across the international cohort to identify areas of practice variability in the presentation and management of acute complicated calculous biliary disease.
Status | Completed |
Enrollment | 250 |
Est. completion date | January 31, 2019 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 110 Years |
Eligibility |
- Inclusion Criteria: - Adult patients (over 18 years of age) admitted for: - Acute gangrenous or perforated calculous cholecystitis (AAST Severity Grade II or above) - Choledocholithiasis or complications of cholelithiasis and/or choledocholithiasis - Biliary Pancreatitis - Procedures which should be included: 1. Cholecystectomy (open, laparoscopic or robotic) 2. Choledochotomy/common bile duct exploration (open, laparoscopic or robotic) 3. Pancreatic necrosectomy 4. Gastrojejunostomy 5. Cyst gastrostomy 6. Endoscopic retrograde choledochopancreatography (ERCP) or Endoscopic ultrasound (EUS) 7. Percutaneous cholecystostomy (transhepatic or transperitoneal) 8. Percutaneous transhepatic drainage, stone removal or stent placement - Exclusion Criteria: - Uncomplicated biliary colic - Biliary dyskinesia - Acute calculous cholecystitis (AAST Grade I) |
Country | Name | City | State |
---|---|---|---|
Ireland | Tallaght University Hospital | Dublin |
Lead Sponsor | Collaborator |
---|---|
European Socierty for Trauma and Emergency Surgery |
Ireland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mortality | Overall and disease-related mortality | 60 days | |
Secondary | ICU Admission | Intensive Care Unit admission for organ-supportive therapy | 60 days | |
Secondary | Length of hospital stay | Length of hospital stay | 60 days | |
Secondary | Complications | Complication related to surgical, endoscopic or radiologic intervention | 60 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04542512 -
Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.
|